Marker Therapeutics Inc (MRKR)
3.94
-0.15
(-3.62%)
USD |
NASDAQ |
May 22, 16:00
3.92
-0.02
(-0.51%)
After-Hours: 20:00
Marker Therapeutics Price to Book Value: 2.981 for May 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 22, 2024 | 2.981 |
| May 21, 2024 | 3.093 |
| May 20, 2024 | 3.178 |
| May 17, 2024 | 3.140 |
| May 16, 2024 | 3.102 |
| May 15, 2024 | 3.155 |
| May 14, 2024 | 3.011 |
| May 13, 2024 | 3.094 |
| May 10, 2024 | 3.125 |
| May 09, 2024 | 3.200 |
| May 08, 2024 | 3.231 |
| May 07, 2024 | 3.042 |
| May 06, 2024 | 3.110 |
| May 03, 2024 | 3.191 |
| May 02, 2024 | 3.176 |
| May 01, 2024 | 3.108 |
| April 30, 2024 | 3.062 |
| April 29, 2024 | 3.112 |
| April 26, 2024 | 3.244 |
| April 25, 2024 | 3.300 |
| April 24, 2024 | 3.327 |
| April 23, 2024 | 3.346 |
| April 22, 2024 | 3.168 |
| April 19, 2024 | 3.130 |
| April 18, 2024 | 3.100 |
| Date | Value |
|---|---|
| April 17, 2024 | 3.259 |
| April 16, 2024 | 3.327 |
| April 15, 2024 | 3.357 |
| April 12, 2024 | 3.259 |
| April 11, 2024 | 3.478 |
| April 10, 2024 | 3.667 |
| April 09, 2024 | 3.550 |
| April 08, 2024 | 3.557 |
| April 05, 2024 | 3.527 |
| April 04, 2024 | 3.686 |
| April 03, 2024 | 3.436 |
| April 02, 2024 | 3.293 |
| April 01, 2024 | 3.474 |
| March 28, 2024 | 2.724 |
| March 27, 2024 | 2.746 |
| March 26, 2024 | 2.737 |
| March 25, 2024 | 3.066 |
| March 22, 2024 | 3.111 |
| March 21, 2024 | 2.940 |
| March 20, 2024 | 2.851 |
| March 19, 2024 | 2.788 |
| March 18, 2024 | 2.737 |
| March 15, 2024 | 2.806 |
| March 14, 2024 | 2.831 |
| March 13, 2024 | 2.742 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3494
Minimum
Mar 30 2023
8.682
Maximum
Mar 22 2021
2.445
Average
2.430
Median
Sep 13 2021
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 5.088 |
| Perspective Therapeutics Inc | 4.036 |
| Protalix BioTherapeutics Inc | 3.175 |
| Electromed Inc | 3.308 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| Price | 3.94 |
| Earnings Yield | -16.24% |
| Market Cap | 35.14M |